Dr. Monk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6529Fax+1 614-293-9469
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1999 - 2002
- OhioHealth/Riverside Methodist HospitalResidency, Internal Medicine, 1996 - 1999
- Ohio State University College of MedicineClass of 1996
Certifications & Licensure
- OH State Medical License 1999 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma Start of enrollment: 2006 Nov 08
- Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer Start of enrollment: 2008 Feb 01
- Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2009 Oct 29
- Join now to see all
Publications & Presentations
PubMed
- 51 citationsCancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer.James A. Eastham, Glenn Heller, Susan Halabi, J. Paul Monk, Himisha Beltran
Journal of Clinical Oncology. 2020-07-24 - 62 citationsImmunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870).Roberto Pili, David I. Quinn, Hans J. Hammers, J. Paul Monk, Saby George
Clinical Cancer Research. 2017-12-01 - 366 citationsRandomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant...William Kevin Kelly, Susan Halabi, Michael A. Carducci, Daniel J. George, John Francis Mahoney
Journal of Clinical Oncology. 2012-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: